Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the best money-making stocks to buy right now. On February 13, Morgan Stanley trimmed the price target on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to $360 from $408 and reiterated an Equal Weight rating, TheFly reported. In a research note, the analyst said that although near-term pressures exist, the preannounced fourth-quarter revenue and reaffirmed 2026 TTR sales guidance reflect increased confidence in the launch. On the same day, RBC Capital al ...